BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7380361)

  • 1. [The mechanism of anti-vascular permeability of 2-(2-fluoro-4-biphenylyl) propionic acid(Flurbiprofen) (author's transl)].
    Yamamoto S; Higuchi Y
    Nihon Yakurigaku Zasshi; 1980 Jan; 76(1):45-9. PubMed ID: 7380361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of anti-inflammatory action of 2-(2-fluoro-4-biphenylyl) propionic acid (flurbiprofen)].
    Masumoto S; Masuda C
    Nihon Yakurigaku Zasshi; 1976 Sep; 72(6):753-62. PubMed ID: 188738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-inflammatory action of 2-(2-fluoro-4-biphenylyl) propionic acid (flubiprofen].
    Takase K; Masumoto S; Okumura M
    Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):573-83. PubMed ID: 1238328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of 2-(2-fluoro-4-biphenylyl)propionic acid (Flurbiprofen) on prostaglandin synthesis].
    Masumoto S; Masuda C
    Nihon Yakurigaku Zasshi; 1976 Nov; 72(8):1025-31. PubMed ID: 1035562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of bradykinin-induced vascular permeability increase by prostaglandin E2 and arachidonic acid in rabbit skin.
    Ikeda K; Tanaka K; Katori M
    Prostaglandins; 1975 Nov; 10(5):747-58. PubMed ID: 1215537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of adrenal and gonadal hormones on vascular permeability in rat skin.
    Ottlecz A; Gecse A; Faragó M; Forster T; Telegdy G
    Endokrinologie; 1979 Apr; 74(1):57-62. PubMed ID: 510225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ACTH on prostaglandin induced vascular permeability.
    Gecse A; Ottlecz A; Farago M; Forster T; Telegdy G
    Acta Physiol Acad Sci Hung; 1980; 55(4):305-11. PubMed ID: 6258391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flurbiprofen: highly potent inhibitor of prostaglandin synthesis.
    Nozu K
    Biochim Biophys Acta; 1978 Jun; 529(3):493-6. PubMed ID: 96864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators.
    Fantone JC; Kunkel SL; Ward PA; Zurier RB
    J Immunol; 1980 Dec; 125(6):2591-6. PubMed ID: 7430639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene B4: a mediator of vascular permeability.
    Bray MA; Cunningham FM; Ford-Hutchinson AW; Smith MJ
    Br J Pharmacol; 1981 Mar; 72(3):483-6. PubMed ID: 6266567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia).
    Johnston MG; Hay JB; Movat HZ
    Agents Actions; 1976 Nov; 6(6):705-11. PubMed ID: 1008016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions.
    Tsurumi K; Kyuki K; Niwa M; Mibu H; Fujimura H
    Arzneimittelforschung; 1986 Dec; 36(12):1801-5. PubMed ID: 3105545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of alpha-(p-thenoylphenyl)-propionic acid (TN-762) on acute inflammatory reactions and prostaglandin biosynthesis].
    Fujimura H; Tsurumi K; Nakayama T; Kokuba S; Hiramatsu Y; Tamura Y
    Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):321-36. PubMed ID: 7052360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species difference in increased vascular permeability by synthetic leukotriene C4 and D4.
    Ueno A; Tanaka K; Katori M; Hayashi M; Arai Y
    Prostaglandins; 1981 Apr; 21(4):637-48. PubMed ID: 6894798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin and prostaglandin E1, E2 and F2alpha-induced macromolecular leakage in the hamster cheek pouch.
    Svensjö E
    Prostaglandins Med; 1978 Nov; 1(5):397-410. PubMed ID: 724817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vasoactive agents on polymorphonuclear leukocyte emigration in vivo.
    Issekutz AC
    Lab Invest; 1981 Sep; 45(3):234-40. PubMed ID: 6944561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperalgesia after treatment of mice with prostaglandins and arachidonic acid and its antagonism by anti-inflammatory-analgesic compounds.
    James GW; Church MK
    Arzneimittelforschung; 1978; 28(5):804-7. PubMed ID: 312105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some biological properties of flurbiprofen, an anti-inflammatory, analgesic and antipyretic agent.
    Adams SS; McCullough KF; Nicholson JS
    Arzneimittelforschung; 1975 Nov; 25(11):1786-91. PubMed ID: 1081878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of forskolin on alterations of vascular permeability induced with bradykinin, prostaglandin E1, adenosine, histamine and carrageenin in rats.
    Sugio K; Daly JW
    Life Sci; 1983 Jul; 33(1):65-73. PubMed ID: 6683350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.